EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS
Delisted
EPRS was delisted on the 3rd of August, 2016.
37 hedge funds and large institutions have $34.8M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.53M | |
| 2 | +$67.5K | |
| 3 | +$41.1K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.1K |
| 5 |
Bank of New York Mellon
New York
|
+$38.4K |
Top Sellers
| 1 | -$795K | |
| 2 | -$669K | |
| 3 | -$290K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$269K |
| 5 |
ST
Spot Trading
Chicago,
Illinois
|
-$187K |